DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
67.40
-1.03 (-1.51%)
At close: Jan 9, 2026, 4:00 PM EST
67.55
+0.15 (0.22%)
After-hours: Jan 9, 2026, 7:24 PM EST
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$438,437
Profits / Employee
$69,971
Market Cap
26.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10,300 | 700 | 7.29% |
| Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 600 | 9.38% |
| Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
| Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
| Dec 31, 2018 | 3,900 | 910 | 30.43% |
| Dec 31, 2017 | 2,990 | 690 | 30.00% |
| Dec 31, 2016 | 2,300 | 791 | 52.42% |
| Dec 31, 2015 | 1,509 | 448 | 42.22% |
| Dec 31, 2014 | 1,061 | 296 | 38.69% |
| Dec 31, 2013 | 765 | 67 | 9.60% |
| Dec 31, 2012 | 698 | 78 | 12.58% |
| Dec 31, 2011 | 620 | 100 | 19.23% |
| Dec 31, 2010 | 520 | 135 | 35.06% |
| Dec 31, 2009 | 385 | 81 | 26.64% |
| Dec 31, 2008 | 304 | 52 | 20.63% |
| Dec 31, 2007 | 252 | -8 | -3.08% |
| Dec 31, 2006 | 260 | 105 | 67.74% |
| Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DXCM News
- 2 days ago - Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer - Business Wire
- 16 days ago - HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 18 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit – DXCM - GlobeNewsWire
- 22 days ago - Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 24 days ago - 4 Reasons Why DexCom Could Be A Good Buy For 2026 - Seeking Alpha
- 4 weeks ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM - PRNewsWire
- 4 weeks ago - High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth - Seeking Alpha
- 5 weeks ago - Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights Before Upcoming Deadlines - GlobeNewsWire